Operating Income Summary of Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited's latest annual operating income in 2023 was 208.05 Million INR , up 40.01% from previous year.
Kilitch Drugs (India) Limited's latest quarterly operating income in 2024 Q1 was 8.07 Million INR , down -86.86% from previous quarter.
Kilitch Drugs (India) Limited reported an annual operating income of 148.59 Million INR in 2022, up 48.36% from previous year.
Kilitch Drugs (India) Limited reported an annual operating income of 100.15 Million INR in 2021, up 142.27% from previous year.
Kilitch Drugs (India) Limited reported a quarterly operating income of 208.05 Million INR for 2023 FY, up 40.01% from previous quarter.
Kilitch Drugs (India) Limited reported a quarterly operating income of 82.92 Million INR for 2023 Q2, up 53.86% from previous quarter.

Annual Operating Income Chart of Kilitch Drugs (India) Limited (2023 - 2006)

Historical Annual Operating Income of Kilitch Drugs (India) Limited (2023 - 2006)

Year	Operating Income	Operating Income Growth
2023	208.05 Million INR	40.01%
2022	148.59 Million INR	48.36%
2021	100.15 Million INR	142.27%
2020	41.34 Million INR	589.94%
2019	-8.43 Million INR	-112.28%
2018	68.69 Million INR	-30.79%
2017	99.26 Million INR	186.96%
2016	-114.14 Million INR	1.85%
2015	-116.28 Million INR	-1126.27%
2014	-9.48 Million INR	-189.2%
2013	10.63 Million INR	-67.54%
2012	32.75 Million INR	-96.64%
2011	973.62 Million INR	483.28%
2010	166.92 Million INR	-7.69%
2009	180.82 Million INR	42.3%
2008	127.07 Million INR	-0.13%
2007	127.23 Million INR	851.45%
2006	13.37 Million INR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	8.07 Million INR	-86.86%
2023 FY	208.05 Million INR	40.01%
2023 Q2	82.92 Million INR	53.86%
2023 Q1	53.89 Million INR	-14.72%
2023 Q3	44.21 Million INR	-46.68%
2023 Q4	61.48 Million INR	39.06%
2022 FY	148.59 Million INR	48.36%
2022 Q2	33.05 Million INR	27.27%
2022 Q3	37.39 Million INR	13.13%
2022 Q4	63.19 Million INR	68.98%
2022 Q1	25.97 Million INR	-56.94%
2021 Q1	19.35 Million INR	-31.43%
2021 Q2	29.59 Million INR	52.92%
2021 Q3	5.64 Million INR	-80.92%
2021 Q4	60.32 Million INR	968.4%
2021 FY	100.15 Million INR	142.27%
2020 Q3	32.8 Million INR	1.63%
2020 FY	41.34 Million INR	589.94%
2020 Q2	32.27 Million INR	394.56%
2020 Q1	-10.95 Million INR	0.0%
2020 Q4	28.22 Million INR	-13.96%
2019 Q3	18.88 Million INR	-10.95%
2019 Q2	21.2 Million INR	2514.8%
2019 Q1	811 Thousand INR	-99.11%
2019 Q4	-10.95 Million INR	-158.02%
2019 FY	-8.43 Million INR	-112.28%
2018 Q3	-19.44 Million INR	-130.65%
2018 FY	68.69 Million INR	-30.79%
2018 Q4	90.89 Million INR	567.56%
2018 Q2	63.43 Million INR	87.8%
2018 Q1	33.77 Million INR	0.0%
2017 FY	99.26 Million INR	186.96%
2016 FY	-114.14 Million INR	1.85%
2015 FY	-116.28 Million INR	-1126.27%
2014 Q3	-16.19 Million INR	-542.27%
2014 Q2	3.66 Million INR	194.26%
2014 Q1	-3.88 Million INR	90.54%
2014 Q4	-10.27 Million INR	36.53%
2014 FY	-9.48 Million INR	-189.2%
2013 Q3	-4.82 Million INR	-176.35%
2013 Q2	-1.74 Million INR	38.46%
2013 Q1	-2.83 Million INR	96.15%
2013 Q4	-41.08 Million INR	-751.52%
2013 FY	10.63 Million INR	-67.54%
2012 Q3	6.34 Million INR	489.5%
2012 Q2	-1.62 Million INR	-105.6%
2012 FY	32.75 Million INR	-96.64%
2012 Q1	29.07 Million INR	0.0%
2012 Q4	-73.77 Million INR	-1262.7%
2011 FY	973.62 Million INR	483.28%
2010 FY	166.92 Million INR	-7.69%
2009 FY	180.82 Million INR	42.3%
2008 FY	127.07 Million INR	-0.13%
2007 FY	127.23 Million INR	851.45%
2006 FY	13.37 Million INR	0.0%

Peer Operating Income Comparison of Kilitch Drugs (India) Limited

Name	Operating Income	Operating Income Difference
Alembic Pharmaceuticals Limited	5.75 Billion INR	96.387%
Hester Biosciences Limited	364.77 Million INR	42.964%
Aarti Drugs Limited	7.14 Billion INR	97.09%
Aarti Pharmalabs Limited	3.12 Billion INR	93.349%
Albert David Limited	1.33 Billion INR	84.409%
Alembic Limited	767.77 Million INR	72.902%
Alkem Laboratories Limited	19.46 Billion INR	98.931%
Bafna Pharmaceuticals Limited	237.66 Million INR	12.459%
Bajaj HealthCare Limited	- INR	-Infinity%
Biofil Chemicals and Pharmaceuticals Limited	20.65 Million INR	-907.213%
Brooks Laboratories Limited	-72.25 Million INR	387.951%
Eris Lifesciences Limited	5.18 Billion INR	95.985%
FDC Limited	3.03 Billion INR	93.142%
Glenmark Life Sciences Limited	8.97 Billion INR	97.683%
Gufic Biosciences Limited	2.89 Billion INR	92.811%
Hikal Limited	1.49 Billion INR	86.076%
Ind-Swift Limited	1.22 Billion INR	83.03%
Innova Captab Limited	2.53 Billion INR	91.788%
IOL Chemicals and Pharmaceuticals Limited	4.94 Billion INR	95.79%
Jagsonpal Pharmaceuticals Limited	214.04 Million INR	2.799%
Jubilant Pharmova Limited	5.18 Billion INR	95.991%
Lincoln Pharmaceuticals Limited	1.9 Billion INR	89.086%
Lupin Limited	27.75 Billion INR	99.25%
Mangalam Drugs & Organics Limited	27.45 Million INR	-657.703%
Medico Remedies Limited	277.11 Million INR	24.924%
Morepen Laboratories Limited	4.17 Billion INR	95.015%
Nectar Lifesciences Limited	3.89 Billion INR	94.652%
Orchid Pharma Limited	2.36 Billion INR	91.188%
Procter & Gamble Health Limited	2.78 Billion INR	92.532%
RPG Life Sciences Limited	2.29 Billion INR	90.924%
Sigachi Industries Limited	1.47 Billion INR	85.884%
Solara Active Pharma Sciences Limited	-3.85 Billion INR	105.4%
Suven Pharmaceuticals Limited	4.6 Billion INR	95.485%
Themis Medicare Limited	1.3 Billion INR	84.034%
Unichem Laboratories Limited	- INR	-Infinity%
Vaishali Pharma Limited	6.29 Million INR	-3205.529%
Wanbury Limited	1.7 Billion INR	87.813%
Windlas Biotech Limited	1.29 Billion INR	83.982%
ZIM Laboratories Limited	1.09 Billion INR	81.054%
Ind-Swift Laboratories Limited	2 Billion INR	89.644%
Ipca Laboratories Limited	29.59 Billion INR	99.297%
Sun Pharmaceutical Industries Limited	104.3 Billion INR	99.801%
Venus Remedies Limited	534.65 Million INR	61.087%
Sakar Healthcare Limited	495.5 Million INR	58.013%
Aurobindo Pharma Limited	104.5 Billion INR	99.801%
Divi's Laboratories Limited	18.31 Billion INR	98.864%
AstraZeneca Pharma India Limited	4.47 Billion INR	95.35%
Mankind Pharma Limited	40.86 Billion INR	99.491%
Sequent Scientific Limited	- INR	-Infinity%
Laurus Labs Limited	3.94 Billion INR	94.731%
Neuland Laboratories Limited	5.31 Billion INR	96.088%
J. B. Chemicals & Pharmaceuticals Limited	7.54 Billion INR	97.241%
Glenmark Pharmaceuticals Limited	6.5 Billion INR	96.8%
Zydus Lifesciences Limited	45.39 Billion INR	99.542%
Amrutanjan Health Care Limited	621.02 Million INR	66.499%
Wockhardt Limited	140 Million INR	-48.607%
Bal Pharma Limited	214.56 Million INR	3.038%
Dr. Reddy's Laboratories Limited	67.72 Billion INR	99.693%
Bliss GVS Pharma Limited	1.23 Billion INR	83.099%
Par Drugs and Chemicals Limited	551.58 Million INR	62.282%
Caplin Point Laboratories Limited	7.22 Billion INR	97.121%
Shilpa Medicare Limited	3.76 Billion INR	94.469%
Valiant Laboratories Limited	- INR	-Infinity%
Ajanta Pharma Limited	19.67 Billion INR	98.943%
Aarey Drugs & Pharmaceuticals Limited	2.83 Million INR	-7249.445%
Granules India Limited	6.52 Billion INR	96.813%
Medicamen Biotech Limited	- INR	-Infinity%
Syncom Formulations (India) Limited	249.25 Million INR	16.53%
Piramal Enterprises Limited	- INR	-Infinity%
Torrent Pharmaceuticals Limited	25.33 Billion INR	99.179%
NATCO Pharma Limited	25.96 Billion INR	99.199%
Suven Life Sciences Limited	-1.22 Billion INR	116.972%
Krebs Biochemicals & Industries Limited	- INR	-Infinity%
Strides Pharma Science Limited	5.22 Billion INR	96.019%
Indoco Remedies Limited	1.52 Billion INR	86.352%
Alpa Laboratories Limited	61.51 Million INR	-238.21%
Lasa Supergenerics Limited	-458 Million INR	145.425%
Sun Pharma Advanced Research Company Limited	-4.11 Billion INR	105.056%

Global Stocks Search

Kilitch Drugs (India) Limited (KILITCH.NS)

Operating Income Summary of Kilitch Drugs (India) Limited

Annual Operating Income Chart of Kilitch Drugs (India) Limited (2023 - 2006)

Historical Annual Operating Income of Kilitch Drugs (India) Limited (2023 - 2006)

Peer Operating Income Comparison of Kilitch Drugs (India) Limited